It's the first time we have mRNA vaccines available, which makes it much easier to update / mix different variations of the virus than earlier technologies. The

It's the first time we have mRNA vaccines available, which makes it much easier to update / mix different variations of the virus than earlier technologies. The mass production is still not optimized, but at least the incentives are huge at this point.